| Human cerebrospinal fluid monoclonal N -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis J Kreye, NK Wenke, M Chayka, J Leubner, R Murugan, N Maier, B Jurek, ... Brain 139 (10), 2641-2652, 2016 | 269 | 2016 |
| Clonal selection drives protective memory B cell responses in controlled human malaria infection R Murugan, L Buchauer, G Triller, C Kreschel, G Costa, ... Science immunology 3 (20), eaap8029, 2018 | 147 | 2018 |
| Natural parasite exposure induces protective human anti-malarial antibodies G Triller, SW Scally, G Costa, M Pissarev, C Kreschel, A Bosch, E Marois, ... Immunity 47 (6), 1197-1209. e10, 2017 | 144 | 2017 |
| Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope K Imkeller, SW Scally, A Bosch, GP Martí, G Costa, G Triller, R Murugan, ... Science 360 (6395), 1358-1362, 2018 | 95 | 2018 |
| Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection SW Scally, R Murugan, A Bosch, G Triller, G Costa, B Mordmüller, ... Journal of Experimental Medicine 215 (1), 63-75, 2018 | 85 | 2018 |
| Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs R Murugan, SW Scally, G Costa, G Mustafa, E Thai, T Decker, A Bosch, ... Nature medicine 26 (7), 1135-1145, 2020 | 79 | 2020 |
| Direct high‐throughput amplification and sequencing of immunoglobulin genes from single human B cells R Murugan, K Imkeller, CE Busse, H Wardemann European journal of immunology 45 (9), 2698, 2015 | 46 | 2015 |
| A putative low-molecular-mass penicillin-binding protein (PBP) of Mycobacterium smegmatis exhibits prominent physiological characteristics of DD-carboxypeptidase and beta-lactamase A Bansal, D Kar, RA Murugan, S Mallick, M Dutta, SD Pandey, ... Microbiology 161 (5), 1081-1091, 2015 | 36 | 2015 |
| A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity E Thai, G Costa, A Weyrich, R Murugan, D Oyen, Y Flores-Garcia, K Prieto, ... Journal of Experimental Medicine 217 (11), e20200061, 2020 | 22 | 2020 |
| From human antibody structure and function towards the design of a novel Plasmodium falciparum circumsporozoite protein malaria vaccine H Wardemann, R Murugan Current opinion in immunology 53, 119-123, 2018 | 15 | 2018 |
| From multiplex serology to serolomics—A novel approach to the antibody response against the SARS-CoV-2 proteome J Butt, R Murugan, T Hippchen, S Olberg, M van Straaten, H Wardemann, ... Viruses 13 (5), 749, 2021 | 14 | 2021 |
| Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies OE Oludada, G Costa, C Burn Aschner, AS Obraztsova, K Prieto, ... EMBO Molecular Medicine 15 (6), e17454, 2023 | 8 | 2023 |
| Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model J Ludwig, SW Scally, G Costa, S Hoffmann, R Murugan, J Lossin, K Prieto, ... npj Vaccines 8 (1), 52, 2023 | 8 | 2023 |
| High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire I Kucharska, Š Binter, R Murugan, SW Scally, J Ludwig, K Prieto, E Thai, ... Plos Pathogens 18 (11), e1010999, 2022 | 7 | 2022 |
| Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein E Thai, R Murugan, Š Binter, CB Aschner, K Prieto, A Kassardjian, ... Cell Reports 42 (11), 2023 | 4 | 2023 |
| Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination Z Li, A Obraztsova, F Shang, OE Oludada, J Malapit, K Busch, ... Immunity, 2024 | | 2024 |
| Somatic hypermutation-mediated paratope flexibility improves the cross-reactivity of human malaria antibodies R Murugan, A Hanke, OE Oludada, G Costa, Y Flores-Garcia, G Mustafa, ... bioRxiv, 2024.07. 24.604858, 2024 | | 2024 |
| High affinity antibodies against the sars-cov-2 receptor binding domain H Wardemann, R Murugan, R Bartenschlager, H Kim WO Patent WO2023156187A1, 2023 | | 2023 |
| Memory B cells dominate the early antibody-secreting cell response to SARS-CoV-2 mRNA vaccination in naive individuals independently of their antibody affinity Z Li, A Obraztsova, F Shang, OE Oludada, J Malapit, K Busch, ... bioRxiv, 2023.12. 01.569639, 2023 | | 2023 |
| PLASMODIUM ANTIBODIES H Wardemann, R Murugan, T Decker, E Levashina, G Costa, J Julien, ... US Patent App. 17/624,046, 2022 | | 2022 |
